Alps Advisors Inc Harmony Biosciences Holdings, Inc. Transaction History
Alps Advisors Inc
- $17.2 Billion
- Q1 2025
A detailed history of Alps Advisors Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 10,473 shares of HRMY stock, worth $361,318. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,473
Previous 9,244
13.3%
Holding current value
$361,318
Previous $318,000
9.12%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HRMY
# of Institutions
278Shares Held
44.9MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$228 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$201 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$162 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$54.5 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$44.5 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.04B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...